NEW YORK, NY April 23, 2015 – About Small Cap Traders and Four Brief Reports

Small Cap Traders makes the connection between sophisticated investors and high quality micro and small cap companies that are currently undervalued. We are an issuer of reports written by experienced financial analysts and who provide a straight forward assessment of a profiled company. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges.

Our Core Values

  • Small Cap Traders doesn’t push pink-sheets.
    Small Cap Traders picks are always stand-and-deliver companies.
    Small Cap Traders picks are always fully reporting NYSE, NASDAQ or OTCQB companies.
    Small Cap Traders works the “Street” like a pro, always providing in-depth analyst reports.
    Small Cap Traders never naps on the job with updates of profiled companies.
    No Credit Card - No Spam - No Obligation

Take the time to learn more about Small Cap Traders by reading one the brief reports below. You will see why our members remain so loyal.

*Special Analyst Alert*

Catasys, Inc. (OTCQB: CATS) recently received a $6 price target on March 6th, 2015 and updated analyst coverage on May 5th, 2015 from Chardan Capital Markets.

http://www.streetinsider.com/Analyst+Comments/Chardan+Capital+Markets+Starts+Catasys+%28CATS%29+at+Buy/10347854.html

Additional analyst coverage was issued today with a $3.25 near term price target.

See this full report here: http://smallcapir.com/wp-content/uploads/2015/05/CATS-MM-BB-IR.pdf

A recent short report on CATS shows a squeeze trigger price of $1.94/share. As well as a golden cross formation in the chart. If CATS holds above the 50 DMA we could see good gains and short covering this week.

If you would like to receive special analyst alerts faster, Text "SmallCap" to 25827

4 Brief Reports:

Advanced Medical Isotope Corp. (OTCBB: ADMD) is a late stage development company engaged in the development of brachytherapy devices for therapeutic applications. Brachytherapy uses radiation to destroy cancerous tumors by placing a radioactive isotope inside or next to the treatment area.

Get a description of the company’s products and details of a capital restructuring in the report you can read here: http://bit.ly/-ADMD--AnalystReport

Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) is a biopharmaceutical company with a pipeline of novel drug candidates in clinical trials for the treatment and diagnosis of cancer. The company's lead immunotherapy candidate, bavituximab, is in Phase III development for the treatment of second-line non-small lung cancer.

Get more details and update s about bavituximab in the report located at this link: http://bit.ly/-PPHM--AnalystReport

Cellceutix Corp. (OTCBB: CTIX) is a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, and antimicrobial applications.

Get a detailed report on the company’s products in the following report including their lead candidate Kevetrin for use in the treatment of certain cancers: http://bit.ly/---CTIX---AnalystReport

Minerco Resources, Inc. (OTCBB: MINE) is an emerging growth company specializing in the food and beverage industry. Its businesses include Level 5 Beverage Company, Inc. (Level 5), Avanzar Sales & Distribution, LLC and The Herbal Collection™. Level 5 brands include VitaminFIZZ®, Vitamin Creamer® and Island Style™.

In the report that follows you can read about the company’s complete exit from the energy business and get updates on its current product lines: http://bit.ly/---MINE---AnalystReport

Forward-Looking Disclaimer   
This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward- looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.   

Compliance Procedure   
Content is researched, written and reviewed on a best-effort basis by a 3rd party research analyst. However, we are only human and may make mistakes. This report was prepared for informational purposes only.  Affiliated parties involved with producing and issuing this report have not been compensated in any form by the profiled company or any related party.  A full disclaimer can be found by viewing the full analyst report. We do not engage in high frequency trading or hold any positions of profiled company. We have not been compensated in any form for these reports.
For more information and services provided beyond this release please use contact information provided below. If you notice any errors or omissions, please notify us below.

A full disclaimer can be found by viewing the analyst report.

If you wish to have a company covered in more detail by our team, or wish to learn more about our services, please contact us at editor@smallcaptraders.com. For any urgent concerns or inquiries please contact us.

Source: Small Cap Traders
Contact: editor@smallcaptraders.com 
 
 

Innovation Pharmaceuticals (PK) (USOTC:IPIX)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Innovation Pharmaceuticals (PK) Charts.
Innovation Pharmaceuticals (PK) (USOTC:IPIX)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Innovation Pharmaceuticals (PK) Charts.